ClostraBio

Chicago, IL · Founded 2016 · Privately Held (backing)

Developer of biopharmaceuticals intended to offer therapeutics for food allergies. ClostraBio is based in Chicago, IL and was founded in 2016. It was valued at $16 million at its later-stage round in Sep 2022, the last priced event on record. It has raised $14.2 million across 1 recorded round; the latest was a $9.9 million early-stage round in Sep 2022.

PMV mark · valuation
$16.0M
Oct 2026
Priced at
its later-stage round
Sep 2022
Total raised
$14.2M
Last round
Early Stage VC
Sep 2022
Cap table — not yet on record

ClostraBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of ClostraBio with a free account
  • ·Watch ClostraBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about ClostraBio

Where does ClostraBio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ClostraBio's 1 recorded funding rounds.